Pds Biotechnology Corp Stock Price To Earnings To Growth
| EU6 Stock | EUR 1.43 0.03 2.14% |
PDS Biotechnology Corp fundamentals help investors to digest information that contributes to PDS Biotechnology's financial success or failures. It also enables traders to predict the movement of PDS Stock. The fundamental analysis module provides a way to measure PDS Biotechnology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PDS Biotechnology stock.
PDS |
PDS Biotechnology Corp Company Price To Earnings To Growth Analysis
PDS Biotechnology's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current PDS Biotechnology Price To Earnings To Growth | (0.29) X |
Most of PDS Biotechnology's fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PDS Biotechnology Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, PDS Biotechnology Corp has a Price To Earnings To Growth of -0.29 times. This is 140.85% lower than that of the Healthcare sector and 109.24% lower than that of the Biotechnology industry. The price to earnings to growth for all Germany stocks is 105.93% higher than that of the company.
PDS Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PDS Biotechnology's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PDS Biotechnology could also be used in its relative valuation, which is a method of valuing PDS Biotechnology by comparing valuation metrics of similar companies.PDS Biotechnology is currently under evaluation in price to earnings to growth category among its peers.
PDS Fundamentals
| Return On Equity | -0.49 | |||
| Return On Asset | -0.25 | |||
| Current Valuation | 189.69 M | |||
| Shares Outstanding | 28.89 M | |||
| Shares Owned By Insiders | 14.20 % | |||
| Shares Owned By Institutions | 23.77 % | |||
| Price To Earning | 23.42 X | |||
| Price To Book | 5.63 X | |||
| EBITDA | (21.43 M) | |||
| Net Income | (16.92 M) | |||
| Cash And Equivalents | 74.75 M | |||
| Cash Per Share | 2.63 X | |||
| Total Debt | 552.98 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 19.22 X | |||
| Book Value Per Share | 1.65 X | |||
| Cash Flow From Operations | (12.49 M) | |||
| Earnings Per Share | (0.91) X | |||
| Price To Earnings To Growth | (0.29) X | |||
| Target Price | 19.71 | |||
| Number Of Employees | 22 | |||
| Beta | 1.91 | |||
| Market Capitalization | 206 M | |||
| Total Asset | 67.2 M | |||
| Net Asset | 67.2 M |
About PDS Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PDS Biotechnology Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PDS Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PDS Biotechnology Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in PDS Stock
When determining whether PDS Biotechnology Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PDS Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pds Biotechnology Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pds Biotechnology Corp Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in PDS Biotechnology Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.